Abstract. Intracellular targeting may enable protein kinases with broad substrate-specificities, such as multifunctional Ca2+/calmodulin-dependent protein kinase (CaM kinase) to achieve a selectivity of action in vivo. We have examined the intracellular targeting of three/i-CaM kinase isoforms. The ~-CaM kinase isoform is targeted to the nucleus in transfected cells while the 8^-and 6c-CaM kinase isoforms are cytosolic/cytoskeletal. A chimeric construct of a-CaM kinase containing the 6B-CaM kinase variable domain is rerouted to the nucleus while the native tx-CaM kinase and chimeras of ix-CaM kinase which contain the ~^-or 6c-CaM kinase variable domains are retained in the cytoplasm. Using site-directed mutagenesis, we have defined a nuclear localization signal (NLS) within an l 1-amino acid sequence, likely inserted by alternative splicing, in the variable domain of ~-CaM kinase. Isoform-specific nuclear targeting of CaM kinase is probably a key mechanism in the selective regulation of nuclear functions by CaM kinase.
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CaM kinase is a multimer that can be composed of several isoforms. We find that when cells express two different isoforms of CaM kinase, cellular targeting is determined by the ratio of the isoforms. When an excess of the cytoplasmic isoform of CaM kinase is coexpressed along with the nuclear isoform, both isoforms are localized in the cytoplasm. Conversely an excess of the nuclear isoform can reroute the cytoplasmic isoform to the nucleus. The nuclear isoform likely coassembles with the cytosolic isoform, to form a beteromultimeric holoenzyme which is transported into the nucleus. These experiments demonstrate isoformspecific targeting of CaM kinase and indicate that such ~argeting can be modified by the expression of multiple isoforms of the enzyme.
ROWTH factors, neurotransmitters and hormones typically modify intracellular processes throughout the cell with high specificity and speed. Their action is often mediated by protein kinases with broad substrate specificities that enable them to coordinate multiple responses. However, the ability of such kinases to phosphorylate many proteins, including non-physiological substrates in vitro, suggests that there must be mechanisms for refining their target specificity in situ. We have examined this issue by studying multifunctional Ca2+/calmodulin-dependent protein kinase (CaM kinase or CaM kinase H), 1 a major intracellular mediator of Ca 2+ action (for review see Hanson and Schulman, 1992b) . Our working model is a modification 1. Abbreviations used in this paper: CaM kinase, multihmetional Ca2+/calmodulin--dependent protein kinase; PKA, cAMP-dependent protein kinase; Ag, antigen; (H), Haemagglutinin peptide-tag; NLS, nuclear localization signal. of the targeting subunit hypothesis (Hubbard and Cohen, 1993) . Stated simply, the hypothesis suggests that a targeting domain (or subunit) directs the catalytic domain (or subunit) of the kinase to the substrate locus. Positioning of the kinase near its substrate or target may occur via a nearby anchoring protein which interacts with the targeting domain or by direct binding of this domain with the substrate. Such targeting, along with spariai/temporal control of the Ca 2+ signal, may underlie target specificity of signal transduction via CaM ldnase.
Some of nature's solutions for specificity have been provided by the study of other kinases and phosphatases. Protein phosphatase 1 is targeted to glycogen or myofibrils by virtue of a targeting subanit which associates with its catalyric subunit (Hubbard and Cohen, 1993) . The type II cAMP-dependent protein kinase (PKA) is targeted via its regulatory subunit to binding proteins on microtubules or postsynaptic density (Scott and Sodeding, 1992) . Protein kinase C has been shown to translocate to receptor proteins that anchor it near its substrates (Smith and Mochly-Rosen, 1992) . Such targeting helps to specify which of the many substrates of the kinase/phosphatase would be phosphorylated/dephosphorylated and to increase the efficiency of the reaction by increasing the local concentration of the kinase/ phosphatase. Distinct patterns of phosphorylation could be achieved in different cell types by the selective expression of a ldnase/phosphatase isoform, intraceUular anchoring protein, and substrates.
CaM kinase is distributed in a wide variety of cell types where it is found localized in the cytosol, cytoskeleton, membrane, and nucleus. Its broad specificity and distribution enables it to phosphorylate substrate proteins localized to the cytosol, cytoskeleton, membrane, and nucleus. It can thus regulate contractility, gene expression, synthesis and release of neurotransmitters, and ion permeation across cell membranes. For example, CaM kinase phosphorylates microtubule-associated protein 2 (MAP-2) and tau on microtubules, phospholamban in sarcoplasmic reticulum, synapsin I on synaptic vesicles, and tyrosine hydroxylase and pyruvate kinase in the cytosol (for review see Hanson and Schulman, 1992b) .
How does CaM kinase participate in regulatory processes in the nucleus? A nuclear localization of a presumably nonneuronal form(s) of CaM kinase has been demonstrated by immunocytochemistry in fibroblasts and glioma cells (Ohta et al., 1990) . Nuclear forms of CaM kinase may be responsible for the increasing number of nuclear functions being attributed to CaM kinase. It regulates nuclear envelope breakdown in sea urchin eggs (Baitingcr et al., 1990) , releases Xcnopus oocytes from meiotic metaphase arrest (Lorca et al., 1993) and promotes maturation of oocytes (Watdmann et at., 1990) , regulates G~-M transition in mammalian cells (Planas-Silva and Means, 1992) , and induces gene expression via the phosphorylation of the CCAAT enhancer element-binding protein/3 (C/EBPfi) (Wegner et al., 1992) . Whereas activation of PICA frees its catalytic subunit so th~ it is no longer excluded from the nucleus (Nigg et al., 1985) , there is no evidence to suggest that CaM kinase dissociates into monomers after activation. The large size of the kinase (a decameric protein of 500-600 kD) makes it unlikely to mediate nuclear events without specific targeting into the nucleus. In the absence of an identified nuclear isoform of multifunctional CaM kinase, some researchers have begun to examine other CaM kinases such as CaM ldnase I and CaM kinase IV which are monomeric and less likely to be excluded from the nucleus.
Multifunctional CaM ldnase is composed of a family of isoforms derived from four (~x, B, 3" and g) closely related genes (for review see Rostas and Dunldey, 1992) . Isoforms range in size from 54 to 60 kD and form multimers of 6-12 subunits that can be larger than 500 kD. The or-and B-CaM kinase isoforms are restricted to the nervous system whereas the 3'-and 6-isoforms are present in essentially all tissues. Each gene may give rise to several isoforms by alternative splicing. Thus, o~ gives rise to ct and c~33 (tie),/$ to fl and if, 3" to 3'^, "re and "re and ~ to at least six isoforms (Bennett and Kennedy, 1987; Benson et al., 1991; Edman and Schulman, 1994; Mayer et at., 1993; Nghiem et at., 1993; Schworer et al., 1993) .
Each CaM kinase isoform encodes a catalytic, regulatory, and association domain. The NHz-terminal half of each isoform consists of the catalytic domain with inherent phosphotransferase activity. Under basal conditions, this activity is suppressed by a regulatory domain containing a kinase autoinhibitory segment and an overlapping ealmodulinbinding segment which follow the catalytic domain. The COOH-terminat domain, termed the association/assembly domain, functions to assemble the subunits into a large multimeric structure and may localize the kinase within the cell by interaction with anchoring proteins. The predominant difference between the isoforms is their variable domain which consists of 11-39 amino acid "inserts" flanking a conserved linker sequence between the catalytic/regulatory and association domains. Electron microscopic studies suggest that in the multimeric holoenzyme, the catalytic/regulatory domains form individual spherical particles which radiate via a short tether from a single central globular panicle formed by all the association domains (Kanaseki et al., 1991) . Alternatively spliced sequences may be inserted on either the NH2-or COOH-terminal side of the conserved linker segment forming the tether. Thus, inserts on the NH2-terminal side may be physically closer to the catalyric/regulatory domain and could modify Ca2+/calmodulin affinity or substrate specificity. Inserts on the COOH-terminal side would be part of the central globular particle and could serve to regulate the multimeric size of the kinase and its targeting to intracellular sites.
Targeting of CaM kinase to distinct subcellular sites may be achieved by a variety of strategies. These include posttranslational modification, targeting of mRNA followed by localized translation, and/or by alternative spliced inserts that direct differential localization within the cell. Some localization of ~x-CaM kinase may be achieved by local synthesis in dendrites, a-CaM kinase mRNA is found in dendrites as well as cell bodies of neurons whereas t-CaM kinase is restricted to cell bodies (Benson et al., 1992; Burgin et al., 1990) . Posttranslational modification of o-CaM kinase may be responsible for some of its targeting since the sarne apparent isoform is found soluble and on synaptic vesicles (Benfenati et al., 1992) .
Molecular cloning of additional CaM kinase isoforms provided us with an opportunity to determine whether isoforms differ in their intracellular localization and to examine the locus responsible for differential localization. We report that ~-CaM kinase, an isoform recently cloned from rat heart, is differentially targeted to the nucleus. By contrast, several other isoforms are excluded from the nucleus. An 11-amino acid insert present in the variable domain of ~-CaM kinase appears to be responsible for the nuclear targeting of CaM kinase.
Materials and Methods

Materials
Restriction enzymes and other DNA modifying enzymes were obtained from OlBCO BRL (Gaithersburg, MD) and New England Biolabs (Beverly, MA). Taq polymerase was obtained from Perkin-Elmer Cetus, (Norwalk, CT). PCR1000.12 cloning vector was obtained from In Vitrogan Corp (San Diego, CA). Antibodies and their sources were as follows: Anti-a-CaM kinase monoctonal antibody, CB-c~-2 (mouse ascites) was generated in our laboratory as described previously (Baitinger et al., 1990) ; auti-hae~..~.~tu-tinin peptide (H) monoclonal antibody, 12CA5 was kindly provided by I. Wilson and is now available commercially through Berkeley Antibody Company (Richmond, CA); rhodamine-labeled anti-mouse affinity pure antibodies were obtained from Orgene Technica Corp. (Durham, NC).
and Thr 4 at the amino-terminal end of 8^-, 6e-, and 8c-CaM kinase, by oligonucleotide-directed mutagenesis (see below). The plasmid chosen for the expression of the wild-type, chimeric, and mutant CaM kinase constructs was the pCD derivative SR~ (Takebe et al., 1988 
Oligonucleotide-directed Mutagenesis
Site-directed mutagenesis of w and a-(8e)-CaM kinase (as M13-CaM kiease) was performed as described previously for a-CaM kinase (Hanson and Schulman, 1992a; Waldmann et al., 1990 Fig. 1 A for amino acid numbering of mutants). Site-directed mutagenesis was also used to "loop-in" a sequence coding for the 18-amino acid haernagglutinin peptide tag sequence (creating H-CaM kinase). The 90-mer oligonucleotide used had the sequence 5'-CCG GGT GCA GGT GGT GGT CAG CTG AGC TCC AGG TCC GC~ GTA GTC AGG GAC GTC GTA CGG ATA AGG AGC TCC CGA AGC CAT GC~ GTC-3' and introduced the amino acid sequence GAPYPYDVP-DYAGPGAQL between Ser 3 and Thr t.
Mutations were identified by restriction analysis and confirmed by single strand DNA sequencing using the enzymatic dideoxynucleotide method with Sequenase (United States Biochem. Corp., Cleveland, OH). Double stranded mutant DNAs were subcloned into a-CaM kinase-SRct or c~-(~d)-CaM kinase-SRa as described above.
PCR Amplification
All PCR reactions were c~gried out using the Twin Block thermal cycler system (Ericomp, Inc., San Diego, CA) and Taq polymerase. The reactions involved an initial denaturation period of 5 rain at 94"C, followed by 25 cycles consisting of I rain at 94"C, 1.5 rain at 55"C, and 2 min at 72"C. Finally the amplification was completed with an additional cycle ending with a 10-rain extension period. Sense oligo-nucleotides containing the Mlul site and antisense oligonucleotides containing the Scal site were used in pairs to amplify the isoform-specific variable sequence of 6^-, 6s-, and 8c-CaM killases.
Expression of CaM Kinase Constructs
COS-7 cells were maintained in DME with 10% supplemented calf serum (Hyclone Labs., Logan, UT) in a 10% CO2 incubator. Rat 208F fibroblast cells were maintained in DME with 10% FBS (Hyclone) in a 10% CO2 incubator. Calcium phosphate transfections were performed essentially as described previously (Chen and Okayama, 1987) . DNA (10-15 pg per lO-cm plate containing ~,70% confluent cells) was added as a coprecipitate with calcium phosphate in buffer containing 25 mM BES buffer, 140 mM NaCi, 130 mM CaCI2, and 0.75 mM Na2HPO4 pH (6.95). Cells were mock transfected by the same procedure but received an SRa plasmid lacking the CaM kinase. Transfected cells were incubated in a 3% CO2 incubator for 16-18 h, transferred to the 10% CO2 incubator with a change of medium, and harvested 36-72 h later. For biochemical studies, the transfected cells were scraped into 10 ml of cold PBS, pelleted gently and resuspended in cold homogenization buffer (50 mM Pipes pH 7.0, 10% glycerol, 1 mM EGTA and a cocktail of the following pmtease inhibitors: Benzamidine 20 mM, PMSF 1 mM, leupeptin 10 ~tg/ml and pepstatin 10 ~g/ml). Cells were disrupted by sonication in a water cup sonicator (Heat Systems-Ultrasonics) at maximal power for 40-60 s at 4°C and cell extracts were prepared by centrifugetion in a microfuge at 13,000 g for 15 rain. Aliquots were snap frozen in dry ice and stored at -700C.
Culture and Transfection of Neonatal Cardiac Myocytes
Neonatal cardiac myocytes were prepared and cultured essentially as described previously (Sen et al., 1988 ) with a few modifications. Briefly whole hearts were isolated from 3-d old rats and minced in a balanced salt solution containing 0.2% glucose. The myocardial cells were dispersed using pancreatin and collaganase type H at 370C, the supernatant was collected and the cells were isolated by centrifugation in a clinical centrifuge at 1,200 rpm for 5 min. The minced hearts were incubated with fresh collagenase and pancreafin and the myocardial ceil isolation procedure repeated. The dispersion steps were repeated, for a total of four times. The cells were pooled and plated at a density of "~1.5 x 106 cells per lO-cm dish in MEM containing 10% horse serum, 5% FCS and 1% antibiotics. More than 95 % of the cells stained positive for myosin indicating that very few flbroblasts were contaminating the myocyte culture. Cultured neonatal cardiac myocytes were transfected 48 h later by calcium phosphate precipitation as described above.
Immunocytofluorescence
Transfected 208F fibroblasts or neonatal cardiac myocytes were transferred 24-36 h later to polylysine-coated glass coverslips. After 12-15 h incubation on the coverslips, the cells were extensively rinsed in PBS and fixed in 2 % HCHO in PBS for l0 rain. The cells were further fixed and permeabilized with cold CH3OH for 3-5 rain. The fixed cells were extensively washed in PBS and preincubated in 1% BSA (RIA grade) in PBS for l h. The cells were further incubated with a primary antibody to either a-CaM kinase or the peptide tag (H), for 2 h at 37"C. The cells were extensively rinsed in PBS and incubated with goat anti-mouse antibody coupled to rhodamine for 45 rain at 370C. The coverslips were mounted on slides with vectashield mounting medium (Vector Labs., Burlingame, CA). The fluorescence was observed using a Zeiss Axioplan Universal microscope using 63x and 100x objectives.
Additional Methods
The activity of the transfected CaM kinases in the cell extract was assayed using a peptide substrate autocamtide 2 as described previously (Hanson et al., 1989) . Assay conditions were similar to that previously described excepting that the specific activity of the ['y-32p]ATP used was 1 Ci/mmole. Immunoblots were performed as previously described (Baitinger et al., 1990 ) using the anti-tag antibody or the anti-a-CaM kinase antibody and incubated for 2 h at room temperature at a dilution of 1:5,000 and 1:2,000, respectively.
Results
Generation and Expression of Epitope Tagged 6-CAM Kinase lsoforms
We chose to examine the effect of isoform-specific inserts on intracellular localization using the &CaM kinase isoforms. &CaM kinase is expressed as multiple alternatively spliced forms (Fig. 1, A and B) which do not differ in their basic physical and catalytic properties (Edman and Schulman, 1994). We examined 6A-CaM kinase, which has a 34-amino acid insert on the COOH-terminal side of the linker segment of the variable domain, B-CaM kinase, which has an ll-amino acid insert, and 6c-CaM kinase, which lacks an insert in this position.
To detect the cellular distribution of the transfected 6-CAM The first lysine of the NLS (K 32s) is the last residue of the linker sequence and is present in all the three 6-CAM kinases. The 18-amino acid HA peptide tag (H) was inserted at the NH2-terminal of the three 6-CAM kinases, by mutagenesis as described in Materials and Methods. (B) Western blot analysis of the recombinant H-~-CaM kinase proteins. Transfected COS cell lysates were subjected to SDS-PAGE and transferred to nitrocellulose. The SRc~ transfected COS cell lysates were similarly immunoblotted as a control. The nitrocellulose blots were probed with anti-tag monoclonal antibody at a dilution of 1:5,000 as described in Materials and Methods. lmmunoblotting of the H-8-CaM kinase transfected COS-'/lysates indicates that the H-6-CaM kinase subunits are specifically recognized by the anti-tag monoclonal antibody and migrate at expected positions on SDS polyacrylamide gel (H-ta-61 kD; H-ts-56 kD; H-tc-CaM kinase-54 kD).
kinases, we introduced an epitope tag into each one. An 18-amino acid segment containing a sequence from hemagglutinin HA1 that constitutes the antigenic epitope for monoclonal antibody 12CA5, was introduced by sitedirected mutagenesis into the three 5-CAM kinases between Ser 3 and ThP, to generate the tagged constructs H-6^-CaM kinase, H-~-CaM kinase, and H-~c-CaM kinase (Field et al., 1988; Wilson et al., 1984) . We checked the basic properties of the three epitope tagged 5-CAM kinases in the SRc~ vector expressed in COS cells (Materials and Methods). Western blotting of SDS-PAGE of COS cell extracts using anti-tag antibody indicates that the three tagged kinases were expressed with a subunit size •2 kD larger than the corresponding subunit lacking the tag (H-~^, 61 kD; H-tB, 56 kD; H-tc, 54 kD) (Fig. 1 B) . Little or no proteolytic prod- Figure 2 . The H-&CaM kinase constructs and the chimeric c~-(6)-CaM kinase constructs exhibit normal enzyme activity. COS cell lysates from ceils transfected with c~-CaM kinase, 8-CAM kinases containing the 18-amino acid haemagglutinin peptide-tag at their amino terminal end (H-6^, H-tB-, H-/tc), or the chimeric c~-(~)-CaM kinases (c¢-(/tA)-, c~-(~)-, c~-(tc)-) were assayed for CaM kinase activity as described in Materials and Methods. The control or endogenous CaM kinase activity in COS ceils was assayed in lysates from COS ceils transfected with the SRc~ expression vector alone.
ucts could be seen in these transfections. Furthermore, only a single prominent band was seen in each lane of the transfected COS cell extracts and no immunoreactivity was seen in the control extract, attesting to the lack of significant cross-reacting antigen in these cells. The presence of the epitope tag did not affect kinase function. Each isoform was expressed as well as a-CaM kinase, a well characterized neuronal isoform (Fig. 2) . Ca2+/calmodulin-dependent phosphorylation of autocamtide-2, a selective CaM kinase substrate, was increased 20-30-fold relative to mock-transfected cells. Kinase activity was highly dependent on both Ca 2÷ and calmodulin. CaM kinase activity migrated on sucrose gradients as a characteristic multimeric holoenzyme of "~500 kD (data not shown) as previously found with the nontagged isoforms (Edman and Schulman, 1994) .
Immunolocalization of H-tA, H-tB, and H-tc-CaM Kinase Transfected into 208F Fibroblasts
The three tagged constructs, in the SR¢ expression vector, were transfected into 208F cells (fibroblasts) in order to determine whether alternative splicing affects the intracellular targeting of 5-CAM kinase. Cells were fixed 36 h after transfection and incubated with the anti-tag antibody (Fig. 3) . A goat anti-mouse IgG coupled to rhodamine was used to detect the mouse monoclonal antibody by fluorescent microscopy. Approximately 20-40% of the cells exhibited immunofluorescence, indicating a transfection efficiency of 20-40%. Expression of H-tA-CaM kinase and H-tc-CaM kinase resulted in a cytosolic immunofluorescence pattern, suggesting that these isoforms were cytosolic or cytoskeletal (Fig. 3, a and b) . There was little or no immunofluorescence in the nucleus. By contrast, all the immunofluorescence in H-SB-CaM kinase expressing cells was nuclear (Fig. 3, c and d). Thus, the transfected H-Se-CaM kinase was almost exclusively targeted to the nucleus. The transfected cells exhibited varying degrees of CaM kinase expression, but in all cases the pattern of staining was identical in that the H-SeCaM kinase was nuclear whereas H-/fA-and H-~c-CaM kinase were cytoplasmic.
Generation and Expression of Chimeric CaM Kinases
Does the 5e-CaM kinase-specific insert encode nuclear targeting information? The only differences in sequence between the three 6-CaM kinase isoforms are the isoform-specific inserts present in 6A" and 5e-CaM kinases and absent in ~c-CaM kinase (Fig. 1 A) . We therefore engineered chimeric kinases in which the 6A" and 5e-specific sequences were introduced in the corresponding position of o~-CaM kinase. Like ~c-CaM kinase, a-CaM kinase lacks inserts at both the NH2-and COOH-terminal sides of the conserved linker sequence and is normally not targeted to the nucleus (see below). Furthermore, a-CaM kinase is the best characterized CaM kinase and an isoform for which a specific antibody is available.
We prepared CaM kinase chimeras to determine whether the /t-specific sequences would reroute a normally cytosolic/cytoskeletal a-CaM kinase. Unique restriction sites were introduced on either site of the variable region of o~-CaM kinase by site-directed mutagenesis (Fig. 4 A) . The variable regions of 6^-, 5e, and 6c-CaM kinases were amplified by PCR using primers that included the identical restriction sites at comparable positions (Fig. 1 A) . This enabled us to generate chimeras with the variable domains of the three 6-CaM kinase isoforms inserted into an identical position of or-CaM kinase (Fig. 4 A) . Expression of the resulting chimeric constructs (referred to from here on as tion with little or no immunofluorescence detected in the cytoplasm despite the high level of expression (Fig. 5, c and  d) . Comparison of the amino acid sequences of a-(~c)-CaM kinase (which has 23 amino acids derived from ~c-CaM kinase) and a-(~)-CaM kinase (which has 34 amino acids derived from B-CaM kinase) shows that there is an l 1-amino acid insert unique to B-CaM kinase (Fig. 1 A) . Since this insert is sufficient to reroute a cytoplasmic a-CaM kinase to the nucleus, it is likely that it encodes information for nuclear targeting which functions independent of the rest of the B-CaM kinase sequence.
Nuclear targeting of B-CaM kinase and a-(~)-CaM kinase does not appear to result from the generation of truncated fragments or unassembled subunits that would be small enough to diffuse passively into the nucleus. We needed to exclude such a possibility since truncated CaM kinase constructs, which lack the association domain, like a-CaM kinase (1-326), are expressed as monomers of ~ 30-35 kD. These monomers express Ca2+/calmodulin-dependent kinase activity and are small enough to passively diffuse into the nucleus (unpublished observations). Several properties of a-(~)-CaM kinase suggest that its nuclear targeting is not due to such an artifact. First, the subunit size of the expressed a-(~)-CaM kinase is commensurate with the size expected of full-length a(Ss)-CaM kinase. A Western blot of cell extracts resolved on SDS-PAGE using the same a-CaM kinase-specific antibody used for immunofluorescence does not detect smaller fragments (Fig. 4 B) . Second, Ca2+/calmodulin-stirnulated phosphorylation of extracts from transfected cells reveals a predominant autophosphorylated 56-kD protein corresponding to a full-length a-(ts)-CaM kinase (data not shown). Third, expressed a-(~s)-CaM kinase assembles appropriately into multimeric holoenzymes as determined by sucrose density centrifugation (data not shown). At least 95 % of CaM kinase activity sediments as a peak of ~500 kD with little activity in fractions sedimenting at the monomer size. Even if a significant fraction of a-(~)-CaM kinase failed to assemble or was made smaller by truncation, it would still not give such a strikingly selective localization in the nucleus as seen above (Fig. 5 c) .
a-(6^)-CaM kinase, ~(~)-CaM kinase, and a-(~c)-CaM kinase) was first examined by transfecting the constructs into COS cells. The protein products were of the expected size and were specifically recognized by a monoclonal antibody to a-CaM kinase (Fig. 4 B) . Each chimera produced a protein kinase which was fully dependent on Ca2+/calmodulin for activity (Fig. 2) . The level of expression was comparable to wild-type a-CaM kinase.
lntracellular Targeting of Chimeric a-(~)-CaM Kinases
a-CaM kinase and the three chimeras were expressed in 208F cells and their intracellular targeting was examined with the anti-a-CaM kinase antibody. Native a-CaM kinase that lacked any 6-CaM kinase sequences was excluded from the nucleus and was broadly distributed within the cell to the cytosol/cytoskeleton (Fig. 5 a) . Similarly, 5(6^)-and a-(~c)-CaM kinases were cytoplasmic, with little immunofluorescence seen in the nucleus (Fig. 5, b and e) . The a-(~)-CaM kinase exhibited a distinctly nuclear localiza-
The 6s-Specific Insert Has a Nuclear Localization Signal
Comparison of the ll-amino acid insert in B-CaM ldnase with established nuclear localization signal (NLS) sequences of known nuclear proteins reveals that it has an NLS similar to that of SV40 T antigen (SV40 TAg). The core NLS of the SV40 T A g , mKKRK (Kalderon et al., 1984a) , is found identically in the B-CaM kinase-specific insert as mKKRK (Fig. 6 ). Does this sequence serve as the NLS that is responsible for nuclear localization of B-CaM kinase? Extensive studies of NLS sequences indicate that the first Lys residue in the sequence KKRK is critical for nuclear targeting. For example, mutation of this Lys in the NLS of SV40 TAg to Ash or Thr disabled nuclear targeting via the NLS and led to the expression of the construct in the cytosol (Lanford and Butel, 1984; Kalderon et aL, 1984a) . We therefore examined the role of the Lys residues in 32*KKRK of ~n-CaM kinase by generating site-directed mutants of a-(~)-CaM kinase in which either the first, second, or first two Lys residues in the KKRK sequence were substituted Figure 6 . Comparison of the insert sequence in the variable domains of 8e-, o~s-, and 7^-CaM kinases with that of the SV40 TAg NLS. The consensus NLS, KKRK, is highlighted in bold. The CaM kinase isoform-specific sequences in the variable domain, which are likely inserted by alternative splicing, are enclosed in a dashed with Asn. We shall use the convention of referring to these mutations as Ly# 2~m, Lys 329~m, or Lys328AsaLys 329Ash, respectively (Fig. 6) . As before, each of these mutated c~-(6e)-CaM kinase chimeras were first characterized in COS cells. All three mutant proteins were expressed at comparable levels and demonstrated the characteristic Ca2+/calmedulinbox. The insertion of the isoform specific sequences generates the NLS sequence, KKRK, in 8e-, ¢xe-, and 1,,-CAM kinase isoforms. The two lysines of the Be-CaM kinase NLS which were mutated to ASH arc Lys 325 and Lys 329. The mutant 8e-CaM kinase NLS sequences (se-Lys 32s~a, 8e-Lys 329Ash, 8e-Lys328ASaLys329A~m) arc highlighted in bold. dependent CaM kinase activity (data not shown). Both the sequencing and functional expression of the mutants indicated that the mutant CaM kinase proteins were full-length. The ,-(~)-CaM kinase chimera, with and without mutations in the putative NLS, were transfected into 208F cells and their intracellular targeting was examined by immunolocalization as above. As previously observed, ~-(~)-CaM kinase was exclusively nuclear (Fig. 7 a) . By contrast, mutation of the Lys 328 to Asn completely blocked the entry of ot-(~)-CaM kinase into the nucleus (Fig. 7 b) . The Lys 32s^s" mutant could not be detected in the nucleus even after 72 h after transfection, thus clearly indicating that the mutation prevents, rather than just slows down the nuclear import. Interestingly, the Lys 329'-mutant was also excluded from the nucleus as was the double mutant Lys 328~* Lyn 329~n. These experiments strongly suggest that this site in ~B-CAM kinase functions as a NLS sequence that is critical for targeting the kinase to the nucleus. Unlike the NLS of SV40 T Ag, both the first and second lysine residues are necessary for nuclear targeting of CaM kinase.
6B-CaM Kinase Is Targeted to the Nucleus in Cardiac Myacytes
We determined the intracellular targeting of H-B-, and H-tc-CaM kinase in cardiac myocytes, since the cDNAs for these isoforms were isolated from a heart library (Edman and Schulman, 1994) . Although B-CaM kinase is targeted to the nucleus in fibroblasts, it is possible that in cardiac cells its NLS is masked or overridden by the anchoring of the kinase to a cytoskeletal or cytosolic protein. We prepared cardiac myocytes from neonatal rats, transfected them with the H-6^-, H-B-, and H-6c-CaM kinase constructs, and followed their localization with the anti-tag antibody as above. 6B-CaM kinase was clearly targeted to the myocyte nucleus (Fig. 8 c) whereas the 6^-and ~c-CaM kinase were excluded from the nucleus and localized to the cytosol/cytoskeleton (Fig. 8, a and b) . We also examined the cellular targeting of the chimeric constructs in the cardiac myocytes. As expected, the H-a-(~)-CaM kinase chimera was targeted exclusively to the nucleus whereas H-or-(6^)-and H-ot-(6c)-CaM kinase were localized to the cytoplasm (data not shown).
Targeting of CaM Kinase Is Determined by the Ratio of Nuclear to Non-Nuclear lsoforms Expressed in the Cell
CaM kinase may consist of holoenzymes with subunits which encode distinct targeting information. This is likely to occur since a number of cell types have been shown to express more than one isoform. Neurons express at least the cx and/3 isoforms of CaM kinase (Scholz et al., 1988) , lymphocytes have at least two 7 isoforms and one 6 isoform (Nghiem et al., 1993) and epithelial cells seem to express both -y and ~ isoforms (Nghiem et al., 1993) . Coexpression of or-and/~-CaM kinase cDNAs in CHO cells leads to the coassembly of or-and fl-CaM kinase subunits to form a holoenzyme (Yamauchi et al., 1989) . Nuclear and nonnuclear isoforms may therefore assemble as heteromultimers and modulate intracellular localization of the two isoforms.
We therefore asked whether nuclear and non-nuclear isoforms can coassemble, whether coassembly occurs before targeting, and whether coassembly affects targeting. We cotransfected various pairwise combinations of nuclear and non-nuclear isoforms in which only one member of any pair contained the epitope tag or could be distinguished by an isoform-specific antibody. Four pairs were tested-H-cx-(&)-CAM kinase with a-CaM kinase, ct-(&)-CaM kinase with H-a-CaM kinase, &-CAM kinase with a-CaM kinase (distinguishable by u-CaM kinase specific antibody), and H-6c-CaM ldnase with ~s-CaM kinase.
We cotransfected H-Sc-CaM kinase (cytosolic isoform) with a large excess (20-fold) of ~-CaM kinase (nuclear isoform) into 208F cells and determined the cellular localization of H-6c-CaM kinase using the anti-tag antibody. Interestingly, greater than 99% of the transfected cells expressed H-6c-CaM kinase in the nucleus (Fig. 9, a and  b) . Since 6c-CaM kinase does not encode a NLS and is localized to the cytoplasm when expressed in the absence of any other isoform (Fig. 3 b) , H-6c-CaM kinase is likely coassembling with the nuclear ~-CaM kinase and the holoenzyme is then being transported into the nucleus by the NLS in the ~-subunits. We obtained an identical result when we cotransfected a-CaM kinase with an excess of ~-CaM kinase. The cytosolic a-CaM kinase was rerouted by the nuclear ~-CaM kinase subunlts and localized almost exclusively in the nucleus (Fig. 9, c and d) . We observed a similar pattern of ceUular staining when an excess of the chimeric t~-(~)-CaM kinase (nuclear isoform) was cotransfected with the H-a-CaM kinase (cytosolic isoform). The H-a-CaM kinase was expressed in the nucleus of transfected cells as determined by anti-H antibody staining (Fig. 9, e and  f) . Thus, an NLS-bearing isoform, either as a chimera or as a naturally occurring isoform can target the entire holoenzyme to the nucleus when it is in excess of the coassembled non-nuclear isoforms.
Cytosolic isoforms determine the cellular targeting when they are the dominant isoform subunits in the holoenzyme. Transfection of a large excess (20-fold) of or-CaM kinase (cytosolic isoform) with H-ot-(~)-CaM kinase (nuclear isoform) results in the localization of H-ot-(~)-CaM kinase in the cytosol in more than 99% of the transfected cells (Fig.  9 g) . A similar pattern of cellular distribution was observed when either 8c-CaM kinase or a-CaM kinase was transfected at a 20:1 ratio to H-~-CaM kinase (data not shown). These experiments indicate that CaM kinase isoforms can coassemble as heteromultimers and that the numerically dominant subunit in the holoenzyme determines its cellular targeting.
Coexpression of the nuclear and the non-nuclear isoforms in intermediate ratios leads to an intermediate distribution of the holoenzyme within the cell. At a 10:1 ratio of o~-(~)-CaM kinase to H-a-CaM kinase, 91% of the transfected ceils expressed the cytosolic isoform in the nucleus (Table D. Decreasing the ratio of o~-(~)-CaM kinase to a-CaM kinase led to the localization of or-CaM kinase in both the cytoplasm and the nucleus. Thus, at a ratio of 1:1, less than 2% of the transfected cells expressed H-a-CaM kinase exclusively in the nucleus while 67 % of the cells expressed H-c~-CaM kinase equally in the nucleus and in the cytoplasm. Conversely, as the ratio of o~-CaM kinase to H-ot-(~)-CaM kinase was increased, none of the transfected cells expressed CaM kinase in the nucleus and an increasing number of cells expressed the nuclear H-~-(~)-CaM kinase isoform in the cytosol (Table I) nase exclusively in the cytoplasm. These experiments clearly demonstrate that the ratio of the two isoforms in a holoenzyme can determine the intracellular distribution of the CaM kinase holoenzyme.
Discussion
This paper directly demonstrates isoform-specific targeting of multifunctional CaM kinase. The enzyme has been known to localize at a variety of intracellular sites and it seemed reasonable to expect that its localization in a given cell would depend on the specific isoform being expressed and the complement of anchoring proteins that the kinase may bind (Rostas and Dunldey, 1992) . Its differential concentration in postsynaptic density from forebrain and cerebellum was postulated to be a result of targeting of the kinase to this neuronal specialization by the a-CaM kinase isoform (Miller and Kennedy, 1985) . We approached this issue directly by testing the targeting of distinct CaM kinase isoforms introduced into cells by transfection and identified a nuclear isoform of the enzyme. We show that an NLS in a 11-amino acid insert sequence at the beginning of the association domain of the ~-CaM kinase is responsible for targeting this isoform, ~-CaM kinase, to the nucleus. This NLS is similar to the NLS of the SV40 TAg and fits the NLS consensus sequence, K-K/R-X-K/R, proposed by Chelsky and coworkers (Chelsky et al., 1989; Garcia-Bustos et al., 1991) . We have demonstrated that the first two lysines of the NLS are critical for nuclear targeting of CaM kinase as their replacement by asparagine, a neutral amino acid, prevents the nuclear entry of CaM kinase. This NLS acts independently of any distal sequences of the ~-CaM kinase isoform since a chimeric construct of c~-CaM kinase which contains the NLS from the ~-CaM kinase is rerouted from the cytosol to the nucleus. In cardiac myocytes, which express endogenous ~-CaM kinase, the transfected ~-CaM kinase is targeted to the nucleus, suggesting that in its native environment the NLS targets ~-CaM kinase to the nucleus. Finally, we observe that the intracellular targeting of the nuclear isoform is modified by coassembly with other isoforms of CaM kinase, generating a heteromultimeric holoenzyme. The first lysine of the NLS is present in the 6c-CaM kinase isoform which lacks any insert sequence and has the sequence KEST (Fig. 1 A) . In the ~-CaM kinase isoform, the ll-amino acid insert sequence which begins with KRK is inserted between the residues K and E of the sequence KEST. The insert sequences that constitute the variable domain of CaM kinase are likely introduced by alternative splicing. In the case of ~-CaM kinase the insert sequence, KRKSSSSVQMM, is introduced after the last lysine of the previous exon, thus generating the sequence KKRKSSSSV-QMM (Fig. 1 A) . It therefore appears that alternative splicing generates the NLS sequence, KKRK, which is responsible for the nuclear targeting of ~-CaM kinase.
Previous studies, based on kinase activity, immunoreactivity or function suggested the presence of CaM kinase in the nucleus. Sahyoun and coworkers (Sahyoun et al., 1984a, b) found a CaM kinase activity in the nucleus which phosphorylated nuclear matrix proteins and chromatin proteins like HMG17, proteins that have been implicated in the regulation of RNA transcription. Ohta et al. (1990) presented immunocytochemical evidence for a nuclear localization of CaM kinase in fibroblasts and glioma cells (Ohta et al., 1990) . CaM kinase has also been implicated in regulating various nuclear functions including nuclear envelope breakdown, G2-M transition in mitosis and gene expression (Baitinger et al., 1990; Planas-Silva and Means, 1992; Sheng et al., 1991; Wegner et al., 1992) . The isoformspecific targeting of CaM kinase to the nucleus reported here specifically identifies which isoforms may be present in the nucleus and suggests a possible mechanism by which targeting is achieved.
The NLS of the SV40 TAg, of which the ~-CaM kinase NLS is a prototype, has been extensively analyzed. Peptides and mutant constructs with this minimal NLS sequence have been demonstrated to target a variety of reporter proteins to the nucleus (Chelsky et al., 1989; Lanford et al., 1986; Kalderon et al., 1984b) . Recently NLS-binding proteins have been identified which bind and transport the NLScontaining proteins into the nucleus (Adam et al., 1989; Adam and Gerace, 1991) . The NLS has been shown to function independent of its position in the protein (Kalderon et al., 1984b) . The first lysine residue of the NLS (KKRK) is critical for the nuclear targeting of the SV40 TAg (Kalderon et al., 1984a; Lanford and Butel, 1984) . Nuclear proteins more commonly use a bipartite NLS exemplified by nucleoplasmin in which two clusters of positively charged residues separated by ten random amino acids are involved Robbins et al., 1991) . Mutation of residues in any one cluster alone is not sufficient to completely prevent the nuclear targeting of nucleoplasmin. Each cluster encodes a weak nuclear-targeting signal and together the two clusters generate a strong NLS. The mutational analysis of the NLS of CaM kinase is significant in that it clearly demonstrates that unlike the bipartite NLS, this single NLS is necessary and sufficient for its nuclear targeting.
Replacement of either of the first two lysine residues of the NLS of ~B-CaM kinase with asparagine blocks nuclear targeting whereas only the first lysine in the SV40 T Ag NLS is essential. Changes in the other lysine residues of the SV40 TAg NLS cause a partial defect in the nuclear targeting of the TAg but do not completely block it. However, even 72 h after transfection, the Lys 329A' n mutant of o~-(~B)-CaM kinase is still completely excluded from the nucleus, suggesting that the second lysine of the NLS is also essential (Fig.  7) . It is possible that additional sequences in the SV40 T Ag stabilize the interaction of the NLS with the NLS-binding protein and therefore replacement of the lysine residues other than the first one may not disrupt the overall interaction sufficiently.
It is clear that the KKRK sequence, generated by the introduction of the l 1-amino acid sequence by alternative splicing, is the NLS which targets ~-CaM kinase to the nucleus. The chimeric analysis further demonstrates that this NLS functions independently of any &CaM kinase specific sequences. We predict that other CaM kinase isoforms which encode a similar KKRK sequence would be targeted to the nucleus. Both arCaM kinase and 3,A-CaM kinase encode an identical NLS generated by the introduction of an 1 l-amino acid and a 27-amino acid sequence, respectively, at a corresponding position (Fig. 6) . Restricted PCR amplification of brain cDNA has identified a partial a-CaM kinase like cDNA clone containing a 33-bp insert (encoding 11 amino acids), likely inserted by alternative splicing (Benson et al., 199D . Indeed we find that a-CaM kinase containing the O/33 PCR fragment which encodes for the ll-amino acid insert sequence (aB-CaM kinase) is targeted to the nucleus (unpublished observations). Thus, the nuclear localization of orB-CaM kinase further supports the role of the KKRK sequence in targeting CaM kinase to the nucleus.
Nuclear entry of CaM kinase may be modified by phosphorylation or autophosphorylation. The phosphorylation of serine residues near the NLS of a variety of nuclear-targeted proteins like SV40 TAg, modifies their nuclear targeting (Rihs et al., 1991) . The four serine residues immediately following the NLS sequence of/~-CaM kinase are candidates for regulatory phosphorylation. CaM kinase IV phosphorylates a peptide derived from ~A-CaM kinase, that corresponds to the/~ NLS-containing insert sequence (Miyano et al., 1992) . Phosphorylation of these and other serine and threonine residues near the NLS of the nuclear CaM kinase isoforms could further modify the nuclear targeting of CaM kinase.
The targeting of the transfected ~-CaM kinase to the nucleus of cardiac myocytes suggests that even in the native environment of the cardiac cell, the NLS of ~-CaM kinase is available to the NLS-binding proteins and is not masked by an association of the kinase with some other cytosolic or cytoskeletal protein. Rat heart contains both ~-and 6c-CaM kinase isoforms but neither the isoform composition of the holoenzymes nor their localization in myocytes is known (Edman and Schulman, 1994) . Presumably the ratio of nuclear to non-nuclear subunits and the amount of putativeanchoring proteins in the cytoplasm/cytoskeleton will determine the distribution of the endogenous CaM kinase in heart.
Previous studies suggest that the a-and B-CaM kinase isoforms copurify and may therefore exist as a heteromultimer (for review see Rostas and Dunkley, 1992) . Although a direct demonstration is still lacking, antibody specific to a-CaM kinase is reported to immunoprecipitate this isoform along with B-CaM kinase (Miller and Kennedy, 1985) . However, EM analysis suggests that the enzyme consists of homomultimers of either a-or B-CaM kinase (Kanaseki et al., 1991) . The potential for coassembly can be most easily tested by coexpressing identified isoforms and this approach has previously been used to demonstrate coassembly of the two neuronal isoforms (a-and B-CaM kinases) (Yamauchi et al., 1989) . The present study uses the same approach to demonstrate the formation of heteromultimers composed of two non-neuronal isoforms of CaM kinase and of one neuronal and one non-neuronal isoform of CaM kinase. It appears that many cells and tissues express more than one isoform of CaM kinase and we show that several combinations of heteromultimers are possible. It will therefore be necessary to define which specific isoforms can coassemble before cellular targeting of CaM kinase can be understood.
The number of nuclear vs non-nuclear subunits of CaM kinase appear to determine the subeellular targeting of CaM kinase. For example, the gradual decrease of the transfected nuclear isoform as compared to the non-nuclear isoform is accompanied by a decrease in nuclear localization of both subunits and a concomitant increase in their cytosolic/cytoskeletal localization. In a cell, the isoform composition of the holoenzyme is probably dependent on the concentration of each subunit being synthesized and the nature of the as-sociation domain which may place limits on which isoforms coassemble. The level of expression of the individual isoforms could be differentially regulated at the level of RNA transcription, translation, or processing. In addition, CaM kinase mRNA shows distinct localization in the brain. In particular, oeCaM kinase mRNA is present in dendrites but /3-CAM kinase is not (Benson et al., 1992; Burgin et al., 1990) . Thus, the cell body may contain heteromultimers, since mRNAs for both a-and 13-CAM kinase isoforms are present there, whereas dendrites probably contain homomultimers of CaM kinase which contain only or-CaM ldnase subunits. The potential interaction of multiple isoforms of CaM kinase introduces one more level at which the cellular localization of CaM kinase may be regulated and therefore introduces another mechanism for the regulation of its cellular functions.
